Regulatory News:

Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity, today announced its financial calendar for 2025.

February 25, 2025

Publication of revenue for Q4 2024

April 17, 2025

Publication of 2024 financial statements

May 14, 2025

Publication of revenue for Q1 2025

June 11, 2025

Annual shareholders’ meeting

July 23, 2025

Publication of revenue for Q2 2025

September 25, 2025

Publication of mid-year financial statements as of June 30, 2025

October 15, 2025

Publication of revenue for Q3 2025

In addition to regular meetings with the financial community, investors can also find updated information on the company’s website (www.adocia.com).

All corporate information on the company such as its financial statements, its corporate presentation and its status is available on the company’s website, in the Investors’ section “Regulated Information”.

About Adocia

Adocia is a biotechnology company specializing in the discovery and development of therapeutic solutions in the field of metabolic diseases, primarily diabetes and obesity.

The Company has a broad portfolio of drug candidates based on four proprietary technology platforms: 1) The BioChaperone® technology for the development of new generation insulins and products combining different hormones; 2) AdOral®, an oral peptide delivery technology; 3) AdoShell®, an immunoprotective biomaterial for cell transplantation, with an initial application in pancreatic cells transplantation; and 4) AdoGel®, a long-acting drug delivery platform.

Adocia holds more than 25 patent families. Based in Lyon, the company has about 80 employees. Adocia is listed on the regulated market of Euronext™ Paris (Euronext: ADOC; ISIN: FR0011184241).

Adocia

Olivier Soula CEO

contactinvestisseurs@adocia.com +33 (0)4 72 610 610 www.adocia.com

Ulysse Communication

Adocia Press & Investor Relations Bruno Arabian Nicolas Entz

adocia@ulysse-communication.com + 33 (0)6 87 88 47 26

Adocia (EU:ADOC)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more Adocia Charts.
Adocia (EU:ADOC)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more Adocia Charts.